Price T Rowe Associates Inc Alector, Inc. Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Alector, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,875,264 shares of ALEC stock, worth $9.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,875,264
Previous 676,313 620.86%
Holding current value
$9.75 Million
Previous $832,000 720.43%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$0.9 - $1.63 $3.78 Million - $6.84 Million
4,198,951 Added 620.86%
4,875,264 $6.83 Million
Q1 2025

May 14, 2025
SELL
$1.23 - $2.06 $85,823 - $143,736
-69,775 Reduced 9.35%
676,313 $832,000
Q4 2024

Feb 14, 2025
SELL
$1.72 - $6.06 $121,036 - $426,442
-70,370 Reduced 8.62%
746,088 $1.41 Million
Q3 2024

Nov 14, 2024
SELL
$4.34 - $6.58 $230,540 - $349,529
-53,120 Reduced 6.11%
816,458 $3.81 Million
Q2 2024

Aug 14, 2024
SELL
$4.19 - $6.23 $87,638 - $130,306
-20,916 Reduced 2.35%
869,578 $3.95 Million
Q1 2024

May 15, 2024
SELL
$5.69 - $8.08 $1.77 Million - $2.51 Million
-311,055 Reduced 25.89%
890,494 $5.36 Million
Q4 2023

Feb 14, 2024
BUY
$3.77 - $8.39 $205,774 - $457,942
54,582 Added 4.76%
1,201,549 $9.59 Million
Q3 2023

Nov 14, 2023
BUY
$5.2 - $8.77 $2.51 Million - $4.23 Million
482,077 Added 72.5%
1,146,967 $7.43 Million
Q2 2023

Aug 14, 2023
SELL
$5.86 - $7.93 $61,371 - $83,050
-10,473 Reduced 1.55%
664,890 $4 Million
Q1 2023

May 15, 2023
SELL
$5.85 - $9.84 $6.16 Million - $10.4 Million
-1,053,350 Reduced 60.93%
675,363 $4.18 Million
Q4 2022

Feb 14, 2023
SELL
$6.88 - $9.55 $100,984 - $140,174
-14,678 Reduced 0.84%
1,728,713 $16 Million
Q3 2022

Nov 14, 2022
SELL
$8.19 - $13.2 $857,771 - $1.38 Million
-104,734 Reduced 5.67%
1,743,391 $16.5 Million
Q2 2022

Aug 15, 2022
SELL
$7.65 - $14.24 $327,289 - $609,229
-42,783 Reduced 2.26%
1,848,125 $18.8 Million
Q1 2022

May 16, 2022
BUY
$13.02 - $20.78 $183,061 - $292,166
14,060 Added 0.75%
1,890,908 $26.9 Million
Q4 2021

Feb 14, 2022
BUY
$19.35 - $25.54 $192,532 - $254,123
9,950 Added 0.53%
1,876,848 $38.8 Million
Q3 2021

Nov 15, 2021
SELL
$21.65 - $39.49 $16.3 Million - $29.8 Million
-754,915 Reduced 28.79%
1,866,898 $42.6 Million
Q2 2021

Aug 16, 2021
SELL
$15.5 - $22.48 $1.11 Million - $1.61 Million
-71,761 Reduced 2.66%
2,621,813 $54.6 Million
Q1 2021

May 17, 2021
SELL
$14.84 - $22.23 $192,623 - $288,545
-12,980 Reduced 0.48%
2,693,574 $54.2 Million
Q4 2020

Feb 16, 2021
BUY
$9.4 - $16.7 $25.4 Million - $45.2 Million
2,706,554 New
2,706,554 $41 Million

Others Institutions Holding ALEC

# of Institutions
139
Shares Held
54.2M
Call Options Held
29.8K
Put Options Held
13.4K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $165M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email